Viper LT system

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 is procuring a BD Viper LT System, a fully automated, tabletop molecular diagnostic platform designed for low-to-mid volume laboratories. This compact, self-contained system must integrate sample extraction, DNA extraction, amplification, detection, and result interpretation in a single unit, with specific capability to qualitatively detect 14 high-risk HPV genotypes and support primary screening, co-testing, and reflex testing methodologies. The system must be FDA-cleared for both ThinPrep and SurePath liquid-based cytology, capable of delivering 90-120 results daily with walk-away capability, and must integrate with the VA VistA hospital information system for automatic result transmission. Evaluation will be based on best value to the Government considering price and technical acceptability, with vendors required to demonstrate clear compliance with all salient characteristics through cross-referencing in their quotation. The offer due date is April 23, 2026 at 07:00 EDT.

This procurement is designated as a Service-Disabled Veteran-Owned Small Business Sole Source award with a size standard of 1,250 employees under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing). The solicitation incorporates standard Federal Acquisition Regulation clauses for commercial items, including Buy American requirements, and mandates that vendors provide all hardware, software, reagent kits, consumables, patient collection materials, waste systems, and support materials, with reagents stable at room temperature. The system must be supported by an uninterruptible power supply and integrate with VA infrastructure for seamless operational deployment. Pricing must be submitted with FOB destination shipping charges and any available discounts clearly noted, with invoices due after receipt and acceptance by the Government and submitted electronically in accordance with VAAR requirements.